Contact
Please use this form to send email to PR contact of this press release:
Hospira Announces Voluntary Nationwide Recall Of One Lot Of Lidocaine HCI Injection, USP, 2 percent, 20 mg per mL Single-dose Vial, Preservative-free, Due To Particulate Matter
TO: